科前生物
(688526)
| 流通市值：53.46亿 | | | 总市值：53.46亿 |
| 流通股本：4.66亿 | | | 总股本：4.66亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 574,896,175.61 | 373,827,539.24 | 227,536,944.76 | 949,742,023.06 |
| 营业总成本 | 419,561,340.78 | 267,836,114.82 | 135,315,536.88 | 524,371,080.48 |
| 其他经营收益 | | | | |
| 营业利润 | 162,818,755.3 | 129,390,734.57 | 90,202,180.95 | 483,114,299.61 |
| 利润总额 | 161,118,926.39 | 128,738,421.03 | 90,104,990.22 | 481,540,786.27 |
| 净利润 | 144,474,490.61 | 114,723,822.66 | 78,689,127.68 | 416,941,266.13 |
| 每股收益 | | | | |
| 其他综合收益 | -15,754,543 | -27,779,257.48 | -7,104,812.04 | 81,279,244.34 |
| 综合收益总额 | 128,719,947.61 | 86,944,565.18 | 71,584,315.64 | 498,220,510.47 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,145,990,448.6 | 3,026,265,762.09 | 3,110,002,104.34 | 2,927,075,209.45 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,431,661,620.97 | 1,486,937,458.8 | 1,714,572,106.09 | 1,862,130,073.81 |
| 资产总计 | 4,577,652,069.57 | 4,513,203,220.89 | 4,824,574,210.43 | 4,789,205,283.26 |
| 流动负债: | | | | |
| 流动负债合计 | 403,566,436.77 | 386,891,081.03 | 419,166,319.14 | 457,496,389.03 |
| 非流动负债: | | | | |
| 非流动负债合计 | 91,937,142.99 | 95,198,849.15 | 92,998,222.55 | 92,530,569.04 |
| 负债合计 | 495,503,579.76 | 482,089,930.18 | 512,164,541.69 | 550,026,958.07 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,083,335,381.26 | 4,031,715,230.71 | 4,312,559,249.89 | 4,238,780,870.21 |
| 股东权益合计 | 4,082,148,489.81 | 4,031,113,290.71 | 4,312,409,668.74 | 4,239,178,325.19 |
| 负债和股东权益合计 | 4,577,652,069.57 | 4,513,203,220.89 | 4,824,574,210.43 | 4,789,205,283.26 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 630,490,103.79 | 394,143,971.08 | 223,312,296.42 | 946,097,003.53 |
| 经营活动现金流出小计 | 404,419,059.18 | 278,287,524.7 | 172,840,733.12 | 477,555,170.31 |
| 经营活动产生的现金流量净额 | 226,071,044.61 | 115,856,446.38 | 50,471,563.3 | 468,541,833.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,813,130,727.41 | 1,975,803,065.63 | 1,071,865,724.34 | 1,418,469,452.57 |
| 投资活动现金流出小计 | 2,774,779,683.83 | 1,798,974,480.97 | 1,099,982,054.49 | 2,067,361,820.39 |
| 投资活动产生的现金流量净额 | 38,351,043.58 | 176,828,584.66 | -28,116,330.15 | -648,892,367.82 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | 17,692,584 |
| 筹资活动现金流出小计 | 308,898,038.67 | 299,527,412.91 | 576,250.38 | 201,962,377.1 |
| 筹资活动产生的现金流量净额 | -308,898,038.67 | -299,527,412.91 | -576,250.38 | -184,269,793.1 |
| 汇率变动对现金及现金等价物的影响 | -3,533.47 | -15,970.82 | -9,243.55 | -2,056,879.58 |
| 现金及现金等价物净增加额 | -44,479,483.95 | -6,858,352.69 | 21,769,739.22 | -366,677,207.28 |
| 期末现金及现金等价物余额 | 132,321,901.51 | 169,943,032.77 | 198,571,124.68 | 176,801,385.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -6,858,352.69 | - | -366,677,207.28 |
最新报告期：2026-11-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华安证券 | 王莺,万定宇 | 0.57 | 0.74 | 0.90 | 2026-11-08 |
| 财通证券 | 肖珮菁 | 0.55 | 0.73 | 0.91 | 2026-11-01 |
| 西部证券 | 熊航 | 0.73 | 0.85 | 0.96 | 2026-09-02 |
| 招商证券 | 施腾 | 0.65 | 0.78 | 0.91 | 2026-08-30 |
| 财通证券 | 肖珮菁 | 0.70 | 0.85 | 1.01 | 2026-08-27 |